|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash Flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Loss on asset disposal | |||||
| Change in fair value of warrant liabilities | |||||
| Depreciation and amortization | |||||
| Shares issued for services | |||||
| Other | |||||
| Changes in assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Lease right-of-use assets | |||||
| Accounts payable and accrued expenses | |||||
| Lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of promissory note | |||||
| Repayment of promissory note | |||||
| Proceeds from at-the-market sales of common stock, net | |||||
| Proceeds from exercise of common stock warrants | |||||
| Proceeds from public and registered direct offerings, net | |||||
| Proceeds from offerings of common stock and warrants, net | |||||
| Proceeds from private placement of common stock and warrants, net | |||||
| Proceeds from warrant inducement offering, net | |||||
| Net cash provided by financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents, at beginning of year | |||||
| Cash and cash equivalents, at end of year | |||||
| Receivable from transfer agent for warrant exercise proceeds | |||||
| Supplemental disclosure: | |||||
| Initial recognition of warrant liabilities | |||||
| Cash paid for: | |||||
| Income taxes | |||||
| Interest | |||||
Loading...